Krystal Biotech, Inc. KRYS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $55.93M+56.5% | $51.4M+13.0% | $79.37M+192% | $38.33M+146% | $35.73M+3,734% | ||
| $1.52M+7.9% | $1.56M+14.5% | $1.4M+7.7% | $1.3M-27.8% | $1.41M-1.2% | ||
| $13.61M+1.0% | $13.76M+3.1% | $13.15M-1.2% | $14.12M+7.3% | $13.48M+44.9% | ||
| $80.38M+160% | $77.51M+46.7% | $39.66M-32.6% | $52.73M— | $30.97M+94.9% | ||
| $7.15M+15.2% | $2.14M+167% | $1.7M+62.9% | $1.9M+68.3% | $6.2M+392% | ||
| -$63.58M-16.1% | —— | -$4.29M+87.5% | -$10.53M+45.6% | -$54.77M-111% | ||
| -$10.46M+16.1% | $15.67M+545% | —— | —— | -$12.47M-218% | ||
| $5.01M+114% | $103.7M+456% | $38.78M+37.6% | $45.06M+441% | -$36.1M-5,424% | ||
| $73.23M+196% | $75.37M+44.8% | $37.96M-34.3% | $50.83M— | $24.77M+69.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Krystal Biotech, Inc. generate?
- Krystal Biotech, Inc. (KRYS) generated $250.3M in operating cash flow over the trailing twelve months.
- What is Krystal Biotech, Inc.'s free cash flow?
- After $12.9M of capital expenditures, Krystal Biotech, Inc.'s free cash flow was $237.4M over the trailing twelve months, up 76.3% year over year.
- Where does Krystal Biotech, Inc.'s cash flow data come from?
- Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
